Cervilenz

About:

CerviLenz offers a device capable of measuring the cervix length, thereby cutting the risk of preterm pregnancies.

Twitter/X: CerviLenz

Top Investors: JumpStart, Arboretum Ventures, North Coast Ventures, Chrysalis Ventures

Description:

CerviLenz is a new, disposable device that measure vaginal cervical length during a speculum exam. Cervical length is a powerful predictor of preterm birth risk and influences patient management decisions. CerviLenz gives clinicians an immediate, reliable method for measuring the cervix at the point of care. CerviLenz is manufactured and distributed by Cervilenz Inc. headquartered in Chagrin Falls, Ohio.

Total Funding Amount:

$31.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chagrin Falls, Ohio, United States

Founded Date:

1985-01-01

Founders:

Dean Koch, Michael Ross, Rosalyn Baxter-Jones

Number of Employees:

11-50

Last Funding Date:

2016-01-20

IPO Status:

Private

Industries: